Merriman Curhan Downgrades ARIAD Pharma (ARIA) to Sell
Tweet Send to a Friend
Merriman Curhan downgrades ARIAD Pharmaceuticals (Nasdaq: ARIA) from Neutral to Sell.
Today's downgrade follows ARIAD's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Today's downgrade follows ARIAD's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE